Evidence map›Paper›PMID 41934555›Full record

ArticleEJNMMI physics2026

Mitigating bladder signal in

Rui Zuo, Mu Kong, Fei Kang, Chunxiao Zheng, Ying Jiang, Qin Wang, Hua Pang, Zhengjie Wang, Jing Wang

Abstract read
In one paragraph

Article in EJNMMI physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rui Zuo *Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Mu Kong *Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Fei Kang *Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Chunxiao ZhengDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ying JiangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qin WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hua PangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Phua1973@163.com.ORCID http://orcid.org/0000-0001-6601-3208
Zhengjie WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. bkzg1234@163.com.
Jing WangDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China. 13909245902@163.com.

Funding

Chongqing Municipal Science and Technology Bureau CSTB2024TIAD-STX0048Ministry of Science and Technology of the People's Republic of China 2024YFC2419402the National Natural Science Foundation of China 82122033the National Natural Science Foundation of China 82472019the National Natural Science Foundation of China 91959208the National Natural Science Foundation of China 92259304
6 · The paper itself

Abstract

backgroundThe pharmacokinetics of

resultsA total of 18 patients with prostate cancer were prospectively enrolled in this study, 9 patients were scanned on the uMI Panorama GS (FOV = 148 cm), and the other 9 patients were scanned on the uMI Panorama 35 C (FOV = 35 cm). The V images demonstrated a significant reduction in bladder TBR [LAFOV: TBR_SUV: 26.71 (14.50-34.83) vs. TBR_V: 0, P < 0.001; SAFOV: TBR_SUV: 14.56 (12.64-17.97) vs. TBR_V: 0.08 (0-1.42), P < 0.001] and SV [LAFOV: TBR_SUV: 154.06 ± 86.64 cm

conclusionsPatlak V imaging significantly reduces bladder signal intensity and obscuration in

Indexed as

Dynamic whole-body PET/CTPatlakProstate cancerPSMAUrinary bladder activity

Identifiers

PMID41934555
PMCPMC13176365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.